<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00214487</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0107</org_study_id>
    <nct_id>NCT00214487</nct_id>
  </id_info>
  <brief_title>Bifocal Soft Contact Lenses and Their Effect on Myopia Progression in Children and Adolescents.</brief_title>
  <official_title>Bifocal Soft Contact Lenses - Do They Slow Progression of Myopia Relative to Single Vision Soft Contact Lenses in Children and Adolescents?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aller, Thomas A., OD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Aller, Thomas A., OD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether bifocal soft contact lenses are effective
      in controlling the progression of myopia in children and adolescents that exhibit a tendency
      to excessively cross their eyes while reading (esophoria or eso fixation disparity). Several
      studies have demonstrated that bifocal or progressive multifocal spectacles are effective in
      slowing the progression of myopia in children either with near point esophoria and/or with
      inadequate focusing at near. A prominent theory for one cause of myopia progression is that
      poorly focused images on the back of the eye (retina) cause the eye to lengthen, causing an
      increase in myopia. Bifocal contact lenses may reduce this retinal defocus, reducing the
      stimulus to eye elongation, and thus may reduce myopia progression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myopia has become the focus of growing attention and concern because the prevalence of myopia
      appears to increasing in some populations (reaching 90% for some university student
      populations in Asia). There are serious risks to higher levels of myopia, including
      cataracts, glaucoma, retinal detachment and myopic retinal degeneration. Several studies have
      shown mild to moderate control of myopia progressionwith bifocal or multifocal spectacles in
      children with esophoria at near and/or with accommodative deficiencies. Pilot studies by the
      P.I. have suggested that bifocal contact lenses may control myopia progression in children
      with near point eso fixation disparity.

      CONTROL is a controlled, randomized, prospective, double-blind, one year study of the changes
      in myopia in 80-90 subjects from age 8-18 with low to moderate levels of myopia, low levels
      of astigmatism, and eso fixation disparity at near, when fitted with either bifocal soft
      contact lenses or single vision soft contact lenses. The primary outcome measures will be
      cycloplegic refraction and axial length measures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <primary_completion_date type="Actual">March 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Cycloplegic Autorefraction in One Year.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Keratometric Changes at One Year.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Manifest Refraction at One Year.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship Between Residual Fixation Disparity and Myopia Progression.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Cycloplegic Subjective Refraction in One Year</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Axial Length at One Year.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Myopia</condition>
  <condition>Esophoria</condition>
  <condition>Fixation Disparity</condition>
  <arm_group>
    <arm_group_label>Bifocal Contact Lenses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of bifocal contact lenses to control the progression of myopia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single vision soft contact lenses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bifocal Contact Lenses</intervention_name>
    <description>Use of bifocal contact lenses of varying add powers to control the progression of myopia</description>
    <arm_group_label>Bifocal Contact Lenses</arm_group_label>
    <other_name>Bifocal Soft Contact Lenses</other_name>
    <other_name>Hydrophilic Bifocal Contact Lenses</other_name>
    <other_name>Simultaneous Vision Bifocal Contact Lenses</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo Control</intervention_name>
    <description>Single vision soft contact lenses</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Soft Contact Lenses</other_name>
    <other_name>Hydrophilic Contact Lenses</other_name>
    <other_name>Single Vision Soft Contact Lenses</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Myopia between -0.50 and -6.00

          -  Eso fixation disparity at 33cm with distance correction

          -  Astigmatism 1.00 or less

          -  Ability to wear soft contact lenses

        Exclusion Criteria:

          -  Presence of ocular disease preventing wear of contacts

          -  Pregnancy or nursing

          -  Use of certain medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas A. Aller, O.D.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <link>
    <url>http://www.draller.com</url>
    <description>Click here for more information about the CONTROL Study</description>
  </link>
  <reference>
    <citation>Aller TA, Wildsoet C. Bifocal soft contact lenses as a possible myopia control treatment: a case report involving identical twins. Clin Exp Optom. 2008 Jul;91(4):394-9. doi: 10.1111/j.1444-0938.2007.00230.x. Erratum in: Clin Exp Optom. 2008 Sep;91(5):479.</citation>
    <PMID>18601670</PMID>
  </reference>
  <reference>
    <citation>Tarrant J, Severson H, Wildsoet CF. Accommodation in emmetropic and myopic young adults wearing bifocal soft contact lenses. Ophthalmic Physiol Opt. 2008 Jan;28(1):62-72. doi: 10.1111/j.1475-1313.2007.00529.x.</citation>
    <PMID>18201337</PMID>
  </reference>
  <reference>
    <citation>Aller TA. Design of a prospective clinical trial of the use of bifocal soft contact lenses to control myopia progression (CONTROL). Proceedings of the 10th International Myopia Conference 2004:29.</citation>
  </reference>
  <results_reference>
    <citation>Aller TA, Wildsoet C. Results of a one-year prospective clinical trial (CONTROL) of the use of bifocal soft contact lenses to control myopia progression. Ophthalmic and Physiological Optics 26(S1), 8-9.</citation>
  </results_reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <results_first_submitted>June 23, 2014</results_first_submitted>
  <results_first_submitted_qc>June 23, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 22, 2014</results_first_posted>
  <last_update_submitted>June 23, 2014</last_update_submitted>
  <last_update_submitted_qc>June 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aller, Thomas A., OD</investigator_affiliation>
    <investigator_full_name>Thomas A. Aller, OD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Myopia Progression</keyword>
  <keyword>Myopia Control</keyword>
  <keyword>Bifocal Contact Lenses</keyword>
  <keyword>Esophoria</keyword>
  <keyword>Fixation Disparity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease Progression</mesh_term>
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Esotropia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bifocal Contact Lenses</title>
          <description>Use of bifocal contact lenses to control the progression of myopia
Bifocal Contact Lenses: Use of bifocal contact lenses of varying add powers to control the progression of myopia</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Single vision soft contact lenses
Placebo Control: Single vision soft contact lenses</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Numbers reflect those subjects screened, enrolled, randomized with at least one follow up examination.</population>
      <group_list>
        <group group_id="B1">
          <title>Bifocal Contact Lenses</title>
          <description>Use of bifocal contact lenses to control the progression of myopia
Bifocal Contact Lenses: Use of bifocal contact lenses of varying add powers to control the progression of myopia</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Single vision soft contact lenses
Placebo Control: Single vision soft contact lenses</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="38"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="78"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in Cycloplegic Autorefraction in One Year.</title>
        <time_frame>One year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bifocal Contact Lenses</title>
            <description>Use of bifocal contact lenses to control the progression of myopia
Bifocal Contact Lenses: Use of bifocal contact lenses of varying add powers to control the progression of myopia</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Single vision soft contact lenses
Placebo Control: Single vision soft contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Cycloplegic Autorefraction in One Year.</title>
          <units>Diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.22" spread="0.34"/>
                    <measurement group_id="O2" value="-0.78" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Keratometric Changes at One Year.</title>
        <time_frame>One year</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Manifest Refraction at One Year.</title>
        <time_frame>One year</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Relationship Between Residual Fixation Disparity and Myopia Progression.</title>
        <time_frame>One year</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Cycloplegic Subjective Refraction in One Year</title>
        <time_frame>One year</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Axial Length at One Year.</title>
        <time_frame>One year</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Bifocal Contact Lenses</title>
          <description>Use of bifocal contact lenses to control the progression of myopia
Bifocal Contact Lenses: Use of bifocal contact lenses of varying add powers to control the progression of myopia</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Single vision soft contact lenses
Placebo Control: Single vision soft contact lenses</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Investigator acknowledges that the data to be collected is proprietary. The Investigator agrees not to publish, divulge, reveal, disclose or otherwise make available, the data to others without the permission of sponsor unless the data have already been, or are subsequently published or disclosed by order of a court of law. The Investigator will not be free to publish papers dealing with the results of any Research performed under this Agreement without the consent of sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Thomas Aller</name_or_title>
      <organization>Dr. Thomas Aller, Optometrist Inc.</organization>
      <phone>650 871-1816</phone>
      <email>cptreyes@earthlink.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

